JYNT
The Joint Corp.8.93
+0.15+1.71%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
135.63MP/E (TTM)
-Basic EPS (TTM)
-0.01Dividend Yield
0%Recent Filings
8-K
8-K
8-K
Clinic refranchising approved
The Joint Corp. secured lender consent on September 30, 2025, to refranchise all company-owned clinics by December 31, 2025, while extending its revolving credit maturity to August 31, 2027. This one-time waiver sidesteps covenant breaches, requiring sales at fair value with at least 75% cash and zero outstanding loans during transactions. Refranchising sharpens focus on franchising, yet demands swift execution amid negative earnings realities.
8-K
CFO separation agreement finalized
The Joint Corp. finalized a separation agreement on August 22, 2025, with former CFO Jake Singleton, whose role ended June 9, 2025. The deal provides $171,958.50 in severance, $36,193.99 for accumulated time off, $15,000 additional cash, and up to six months of COBRA coverage, in exchange for a full release of claims. Equity awards follow existing terms without acceleration. This resolves the exit cleanly, minimizing disputes.
10-Q
Q2 FY2025 results
The Joint Corp. posted solid Q2 FY2025 results from continuing operations, with total revenues climbing 5.2% y/y to $13.3M on stronger royalty fees and franchise growth, while narrowing its operating loss by 36% y/y to $1.1M amid tighter cost controls. Gross margins held steady at 79.1%, up slightly from 77.7% y/y, as franchise and IT costs dipped 1.4% y/y. Diluted EPS from continuing operations improved to -$0.06 from -$0.11 y/y, reconciling neatly with 15.4M weighted shares. Cash swelled to $29.8M at quarter-end, bolstered by $7.8M from clinic sales under its refranchising push, which closed 37 locations including a $8.3M Arizona/New Mexico cluster deal recognizing no goodwill but freeing up resources. Free cash flow wasn't disclosed in the 10-Q. Yet competition from established chiropractic rivals lingers as a key risk.
IPO
Website
Employees
Sector
Industry
BTMD
Biote Corp.
2.67+0.05
CDIX
Cardiff Lexington Corporation
1.42-0.29
DYNT
Dynatronics Corp.
0.04+0.00
FCHS
First Choice Healthcare Solutio
0.01+0.00
HLYK
HealthLynked Corp.
1.67-0.22
HNGE
Hinge Health, Inc.
48.41-0.09
JRSS
JRSIS Health Care Corp
0.02+0.00
PAIYY
Aesthetic Medical International
0.13+0.00
PIII
P3 Health Partners Inc.
4.59-0.36
YJGJ
Yijia Group Corp.
1.61+0.00